Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy

被引:39
作者
Borrell, A [1 ]
Martinez, JM [1 ]
Serés, A [1 ]
Borobio, V [1 ]
Cararach, V [1 ]
Fortuny, A [1 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Sch Med,Inst Gynecol Obstet & Neonatol, Prenatal Diag Unit,IDIBAPS, Barcelona 08028, Spain
关键词
ductus venosus; nuchal translucency; Down syndrome; fetal aneuploidy; Doppler studies;
D O I
10.1002/pd.716
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective To assess the potential value of ductus venosus Doppler studies in the detection of fetal aneuploidy on measurement of nuchal translucency. Methods The pulsatility index for veins (PIV) and the lowest velocity during atrial contraction (A-wave) were determined in the fetal ductus venosus in 3382 consecutive pregnancies at 10 to 14 weeks and studied from December 1996 to December 2001. Nuchal translucency was also measured. The population studied included 1664 pregnancies at high risk and 1718 at low risk for fetal aneuploidy. Results In relation to the prenatal detection of trisomy 21, the ductus venosus PIV was increased in 75% (36/48) the A-wave was decreased in 58% (28/48), and nuchal translucency was enlarged in 81% (39/48) of the trisomy 21 fetuses [71% (22/31) when nuchal translucency referrals were excluded]. The corresponding figures for trisomies 18 and 13 were 71, 58 and 83%, respectively, being 33, 33 and 33% for other unbalanced anomalies. Conclusion There is a high proportion of fetuses with trisomies 21, 18 and 13 (around 75%) in which the ductus venosus PIV is increased (above the 95th percentile) at 10 to 14 weeks, this proportion being similar to that observed for increased nuchal translucency measurement. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:921 / 926
页数:6
相关论文
共 18 条
  • [1] Safety statement, 2000 -: International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)
    Abramowicz, JS
    Kossoff, G
    Marsál, K
    ter Haar, G
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2000, 16 (06) : 594 - 596
  • [2] The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation
    Antolín, E
    Comas, C
    Torrents, M
    Muñoz, A
    Figueras, F
    Echevarría, M
    Cararach, M
    Carrera, JM
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (04) : 295 - 300
  • [3] Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities:: relationship with nuchal translucency measurement and fetal outcome
    Bilardo, CM
    Müller, MA
    Zikulnig, L
    Schipper, M
    Hecher, K
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (04) : 288 - 294
  • [4] Borrell A, 1997, PRENATAL DIAG, V17, P23, DOI 10.1002/(SICI)1097-0223(199701)17:1<23::AID-PD24>3.3.CO
  • [5] 2-0
  • [6] Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy
    Borrell, A
    Antolin, E
    Costa, D
    Farre, MT
    Martinez, JM
    Fortuny, A
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (06) : 1612 - 1617
  • [7] ULTRASONOGRAPHIC VELOCIMETRY OF THE FETAL DUCTUS VENOSUS
    KISERUD, T
    EIKNES, SH
    BLAAS, HGK
    HELLEVIK, LR
    [J]. LANCET, 1991, 338 (8780) : 1412 - 1414
  • [8] Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks
    Matias, A
    Huggon, I
    Areias, JC
    Montenegro, N
    Nicolaides, KH
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1999, 14 (05) : 307 - 310
  • [9] Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow
    Matias, A
    Gomes, C
    Flack, N
    Montenegro, N
    Nicolaides, KH
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 12 (06) : 380 - 384
  • [10] Mavrides E, 2002, BJOG-INT J OBSTET GY, V109, P1015